PIM kinase inhibitor AZD1208 in conjunction with Th1 cytokines potentiate death of breast cancer cells in vitro while also maximizing suppression of tumor growth in vivo when combined with immunotherapy
-
Published:2024-03
Issue:
Volume:397-398
Page:104805
-
ISSN:0008-8749
-
Container-title:Cellular Immunology
-
language:en
-
Short-container-title:Cellular Immunology
Author:
Anwar ArielORCID,
Lepore Carissa,
Czerniecki Brian J.,
Koski Gary K.,
Showalter Loral E.ORCID